HOME
PRODUCTS
COMPANY
CONTACT
FAQ
Research
Dictionary
Pharma
Sign Up
FREE
or
Login
Username:
Password:
Remember login
Login
Send password reminder...
Virginia Kaklamani Selected Research
Virginia Kaklamani Research Topics
Disease
24
Breast Neoplasms (Breast Cancer)
01/2022 - 04/2004
19
Neoplasms (Cancer)
01/2022 - 01/2003
5
Neoplasm Metastasis (Metastasis)
01/2022 - 10/2005
3
Disease Progression
01/2019 - 05/2007
3
Carcinogenesis
06/2016 - 12/2007
3
Colorectal Neoplasms (Colorectal Cancer)
05/2010 - 05/2005
2
Triple Negative Breast Neoplasms
01/2021 - 01/2020
2
Insulin Resistance
01/2013 - 09/2011
2
Prostatic Neoplasms (Prostate Cancer)
09/2011 - 09/2004
1
Nausea
01/2021
1
Noninfiltrating Intraductal Carcinoma (DCIS)
01/2020
1
Pathologic Complete Response
01/2020
1
Ductal Carcinoma
01/2020
1
Weight Loss (Weight Reduction)
08/2017
1
Fatigue
05/2013
1
Stomatitis
05/2013
1
Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
04/2013
1
Pancreatic Neoplasms (Pancreatic Cancer)
01/2013
1
Malaria
01/2013
1
Liver Diseases (Liver Disease)
01/2013
1
Neutropenia
01/2013
1
Obesity
09/2011
1
Cardiovascular Diseases (Cardiovascular Disease)
08/2010
1
Exanthema (Rash)
08/2010
1
Cardiotoxicity
08/2010
1
Diarrhea
08/2010
1
Acute Myeloid Leukemia (Acute Myelogenous Leukemia)
07/2010
1
Adenocarcinoma
05/2010
1
Colonic Neoplasms (Colon Cancer)
12/2007
Drug/Important Bio-Agent (IBA)
7
Transforming Growth Factor-beta Type I Receptor
IBA
05/2010 - 02/2004
5
Estrogen Receptors
IBA
01/2022 - 11/2006
5
Transforming Growth Factor beta (TGF-beta)
IBA
05/2009 - 01/2003
4
Trastuzumab (Herceptin)
FDA Link
12/2021 - 04/2004
3
Proteins (Proteins, Gene)
FDA Link
01/2022 - 09/2011
3
Biomarkers (Surrogate Marker)
IBA
12/2021 - 01/2010
3
ErbB Receptors (EGF Receptor)
IBA
12/2021 - 01/2020
2
Estrogens (Estrogen)
FDA Link
01/2022 - 06/2016
2
DNA (Deoxyribonucleic Acid)
IBA
01/2022 - 05/2010
2
Everolimus
FDA Link
01/2020 - 01/2019
2
Anthracyclines
IBA
05/2019 - 08/2010
2
taxane
IBA
05/2019 - 08/2010
2
Hormones (Hormone)
IBA
01/2019 - 08/2010
2
human ERBB2 protein
IBA
05/2013 - 01/2013
2
Sorafenib (BAY 43-9006)
FDA Link
05/2013 - 01/2013
2
Capecitabine (Xeloda)
FDA Link
05/2013 - 08/2010
2
Bevacizumab (Avastin)
FDA Link
05/2013 - 04/2004
2
Adiponectin
IBA
01/2013 - 09/2011
1
olaparib
IBA
01/2022
1
carbazole
IBA
01/2022
1
Poly(ADP-ribose) Polymerase Inhibitors
IBA
01/2022
1
Antidepressive Agents (Antidepressants)
IBA
01/2022
1
Imipramine (Janimine)
FDA Link
Generic
01/2022
1
Carboplatin (JM8)
FDA Link
Generic
12/2021
1
Ado-Trastuzumab Emtansine
IBA
12/2021
1
B7-H1 Antigen
IBA
12/2021
1
pertuzumab
IBA
12/2021
1
atezolizumab
IBA
12/2021
1
Docetaxel (Taxotere)
FDA Link
12/2021
1
Triglycerides (Triacylglycerol)
IBA
01/2021
1
RAD1901
IBA
01/2021
1
elacestrant
IBA
01/2021
1
2019-nCoV Vaccine mRNA-1273
IBA
01/2021
1
BNT162 Vaccine
IBA
01/2021
1
mRNA Vaccines
IBA
01/2021
1
COVID-19 Vaccines
IBA
01/2021
1
Phosphorus (Red Phosphorus)
IBA
01/2021
1
Tablets
IBA
01/2021
1
Mechanistic Target of Rapamycin Complex 1
IBA
01/2020
1
Sirolimus (Rapamycin)
FDA Link
01/2020
1
Platinum
IBA
01/2020
1
Matrix Metalloproteinase 9 (Gelatinase B)
IBA
01/2020
1
eribulin
FDA Link
05/2019
1
Cytotoxins (Cytolysins)
IBA
05/2019
1
Pharmaceutical Preparations
IBA
01/2019
1
Protein Isoforms (Isoforms)
IBA
01/2019
1
Growth Factor Receptors
IBA
01/2019
1
Estrogen Receptor alpha
IBA
06/2016
1
Antipsychotic Agents (Antipsychotics)
IBA
06/2014
1
Prolactin Receptors (Prolactin Receptor)
IBA
06/2014
1
Gemcitabine
FDA Link
05/2013
1
Pemetrexed (MTA)
FDA Link
04/2013
1
Folic Acid (Vitamin M)
FDA Link
Generic
04/2013
1
Fulvestrant (Faslodex)
FDA Link
03/2013
1
C-Peptide
IBA
01/2013
1
Paclitaxel (Taxol)
FDA Link
Generic
01/2013
1
Angiogenesis Inhibitors
IBA
01/2012
1
Adiponectin Receptors
IBA
09/2011
1
Letrozole (Femara)
FDA Link
Generic
08/2010
1
Lapatinib (GW572016)
FDA Link
08/2010
1
RNA (Ribonucleic Acid)
IBA
05/2010
1
Cathepsin D
IBA
01/2010
1
Enzymes
IBA
01/2010
1
Transforming Growth Factors (Transforming Growth Factor)
IBA
05/2009
1
Aligeron (AS 2)
IBA
12/2007
Therapy/Procedure
12
Therapeutics
01/2022 - 04/2004
4
Drug Therapy (Chemotherapy)
01/2022 - 01/2012
2
Immunotherapy
12/2021 - 05/2019
1
Precision Medicine
01/2021
1
Neoadjuvant Therapy
01/2020
1
Drug Tapering
05/2013